By Adam Rhodes ( May 22, 2019, 1:29 PM EDT) -- Biotechnology giant Amgen said Wednesday it lobbed a 1.6 billion Swedish kronor ($167 million) cash bid to buy Nuevolution, an offer that has already won a unanimous recommendation in favor from the Scandinavian biopharmaceutical company's board of directors....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.